White Lighthouse Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,810
Closed -$246K 114
2022
Q4
$246K Sell
4,810
-200
-4% -$9.59K 0.07% 100
2022
Q3
$219K Hold
5,010
0.06% 102
2022
Q2
$263K Sell
5,010
-47
-0.9% -$2.4K 0.08% 94
2022
Q1
$262K Hold
5,057
0.07% 97
2021
Q4
$299K Buy
+5,057
New +$251K 0.07% 98
2020
Q2
Sell
-14,690
Closed -$455K 114
2020
Q1
$455K Buy
14,690
+148
+1% +$5.04K 0.19% 79
2019
Q4
$541K Hold
14,542
0.2% 77
2019
Q3
$496K Sell
14,542
-4,425
-23% -$161K 0.2% 78
2019
Q2
$780K Hold
18,967
0.33% 57
2019
Q1
$764K Buy
18,967
+10,836
+133% +$434K 0.35% 59
2018
Q4
$337K Sell
8,131
-605
-7% -$25.1K 0.19% 89
2018
Q3
$365K Sell
8,736
-421
-5% -$16.2K 0.19% 85
2018
Q2
$315K Sell
9,157
-659
-7% -$22.5K 0.17% 91
2018
Q1
$331K Buy
9,816
+2,187
+29% +$75.2K 0.19% 90
2017
Q4
$262K Buy
+7,629
New +$260K 0.15% 103

Other funds holding PFE

White Lighthouse Investment Management's PFE Position: Q1 2023 in Review

White Lighthouse Investment Management sold out of Pfizer (PFE) in Q1 2023, closing a stake of 4,810 shares — an estimated $246K sold.

White Lighthouse Investment Management first reported a position in PFE in Q4 2017 and held it in 15 quarters. The position peaked at $780K in Q2 2019. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • White Lighthouse Investment Management reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
  • White Lighthouse Investment Management sold 4,810 Pfizer shares in Q1 2023, an estimated $246K.
  • White Lighthouse Investment Management first reported a position in Pfizer in Q4 2017 and held it in 15 quarters.
  • White Lighthouse Investment Management's Pfizer position peaked at $780K in Q2 2019.
  • 3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on White Lighthouse Investment Management's 13F filing for Q1 2023, filed 20 Apr 2023.